1 results found

Prem Raj Shrestha, Kalawati Shrestha, Prajwal Pudasaini, Huawei Weng, Tongyu Lin

Background Rituximab based chemotherapy regimens, particularly R-CHOP, are highly effective for the treatment of B-cell lymphoma (BCL) but are frequently complicated by pulmonary adverse effects (PAEs...

BMC Cancer 2026-04-23 rs-9145705
rituximab pulmonary adverse effects thymosin α1 intravenous immunoglobulin event-free survival
Back to Top
Home
Browse
Submit
About
0.031300s